The report highlights international regulators’ plans for the development and availability of...
Author - David Miller
The State of Compounding: Q&A with Olympia...
The CEO discusses the current state of compounding pharmacies and how it built to this point.
Pharma Pulse 10/28/24: Operating Without a Commercial Blueprint...
The latest news for pharma industry insiders.
Outsourcing Compendial Testing for Competitive Advantage
Compendial testing covers a wide array of materials, subjects, and locations designed to create...
AbbVie Agrees to Terms to Acquire Aliada Therapeutics
Acquisition includes Aliada’s lead asset, ALIA-1758, which is being developed for the treatment...
Merck, Moderna Launch Phase III Trial of V940 in Combination...
Collaboration seeks to advance the treatment of non-small cell lung cancer by combining Keytruda...
Long-Term Implications of Ongoing Drug Shortages
Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy...
The Global Stage: Q&A with EVERSANA’s Vikram Anand
The president of compliance services discusses the company’s recent expansion into new markets.
Excipients for Respiratory Delivery of Biologics
Webinar Date/Time: Tuesday, November 12, 2024 at 11am EST | 5pm CET
ICP-MS and ICP-OES: Tools for Elemental Impurity Analysis
Elemental impurity testing is essential to deliver safe drug products to patients and is a...